[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.3.44. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January NaN, 2001

Dextromethorphan and Ecstasy Pills—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;285(4):409-410. doi:10.1001/jama.285.4.407

In Reply: We described another potential complication of MDMA abuse. It is not logical to suggest that by describing possible dextromethorphan toxicity we somehow minimize the dangers of illicit MDMA. The adverse effects of MDMA are well-documented and well-known to medical personnel. We reluctantly omitted an explicit comparison of MDMA and dextromethorphan toxicity due to space constraints but strongly agree that both drugs may produce toxic syndromes with similar signs and symptoms. We also agree that currently available qualitative urine toxicology screening systems may not detect MDMA in as many as one third of samples.

First Page Preview View Large
First page PDF preview
First page PDF preview
×